R&D Spending by U.S. Biopharmaceutical Companies Increases 3 Percent in 2008
12-Mar-2009 -
New statistics just released reveal that R&D investment in new medicines by the biopharmaceutical industry was $65.2 billion in 2008, an increase of 3 percent from 2007, according to a combined analysis conducted by Burrill & Company and the Pharmaceutical Research and Manufacturers of America ...
AIDS
Alzheimer's disease
biotechnology
+5